Letterhead of World Heart Corporation]World Heart Corp • March 31st, 2005 • Electromedical & electrotherapeutic apparatus
The transfer of Novacor is schedule to take effect on June 30, 2000 (the "Closing Date"). Currently, the terms and conditions of your employment, including compensation and employee benefits, are provided in accordance with the plans and policies of Edwards and Novacor. Following the Closing Date, the terms and conditions of your employment, which is a continuation of your current position, will be subject to the compensation and benefit plans and policies of World Heart Corporation through its wholly owned US subsidiary, World Heart Inc. ("WorldHeart"). We are therefore pleased to offer you continued employment with WorldHeart in your current position, effective as of the Closing Date, as described below. As the Novacor and WorldHeart operations are integrated, your current position may change to reflect the business requirements of WorldHeart.
AGREEMENTAgreement • March 31st, 2005 • World Heart Corp • Electromedical & electrotherapeutic apparatus • Ontario
CONSULTING AGREEMENTConsulting Agreement • March 31st, 2005 • World Heart Corp • Electromedical & electrotherapeutic apparatus • Ontario
WHEREAS WorldHeart carries on a business consisting principally of the research, development and commercialization of medical devices (the "Business");
